Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

X

Reynald Castaneda

29 Nov 2021

Analysis

Regulatory roundup: Invokana approval shot increases in heart failure with positive Phase III data

29 Nov 2021

26 Nov 2021

Analysis

Eileen O’Reilly: how pancreatic cancer disease burden can stymie enrolment momentum

26 Nov 2021

25 Nov 2021

Analysis

Eileen O’Reilly: why pancreatic cancer preclinical data is pivotal in trial design

25 Nov 2021

24 Nov 2021

Analysis

Vaxart oral Covid-19 vaccine: could trial execution obstacles delay market entry?

24 Nov 2021

23 Nov 2021

Analysis

Regulatory roundup: AbbVie’s Phase II fail plunges Alzheimer’s contender’s shot at further study

23 Nov 2021

19 Nov 2021

Analysis

Michael Thompson: Covid-19 lessons to optimise cancer clinical trial operations

19 Nov 2021

16 Nov 2021

Analysis

Michael Thompson: beating bureaucracy in oncology trial initiation

16 Nov 2021

16 Nov 2021

Analysis

Regulatory roundup: Sage Alzheimer’s asset likely to progress after Phase IIa completion

16 Nov 2021

12 Nov 2021

Analysis

In conversation: nonalcoholic steatohepatitis investigator Rohit Loomba

12 Nov 2021

09 Nov 2021

Analysis

Vaxine to file for Australian approval of protein subunit Covid-19 vaccine

09 Nov 2021